Results 91 to 100 of about 1,812,091 (361)

Searching for diagnoses and subgroups: a suggestion for criteria

open access: yesFrontiers in Psychiatry
New subgroups of psychiatric disorders are often claimed. In contrast, classification systems have repeatedly had to abandon established subgroups such as paranoid vs. disorganised and catatonic schizophrenia due to lack of empirical evidence.
Tilman Steinert
doaj   +1 more source

Characterization of human rotavirus subgroups and serotypes in children under five with acute gastroenteritis in a Saudi Hospital

open access: yesJournal of Family and Community Medicine, 2011
Objectives: Rotavirus is the most common cause of severe diarrhea in children. Currently, there is no published data on the prevalence of subgroups and serotypes of rotavirus in the Eastern province of Saudi Arabia.
Obeid E Obeid
doaj   +1 more source

Identification of molecular subtypes of coronary artery disease based on ferroptosis- and necroptosis-related genes

open access: yesFrontiers in Genetics, 2022
Aim: Coronary artery disease (CAD) is a heterogeneous disorder with high morbidity, mortality, and healthcare costs, representing a major burden on public health.
Wen-Pan Liu   +9 more
doaj   +1 more source

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis

open access: yesNeurology: Neuroimmunology & Neuroinflammation, 2016
Objectives: To evaluate the presence of antibodies to conformation-intact myelin oligodendrocyte glycoprotein (MOG) in a subgroup of adult patients with clinically definite multiple sclerosis (MS) preselected for a specific clinical phenotype including ...
M. Spadaro   +12 more
semanticscholar   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Subgroups Permutable with All Sylow Subgroups

open access: yesJournal of Algebra, 1998
Die vorliegende Arbeit betrachtet sich als Fortsetzung zu einem Ergebnis von \textit{O. H. Kegel} [Math. Z. 78, 205-221 (1962; Zbl 0102.26802)]. Zudem weist der Verfasser auf Resultate von \textit{P. B. Kleidman} [Ann. Math., II. Ser. 133, No. 2, 369-428 (1991; Zbl 0726.20012)] zur Vermutung von Kegel und Wielandt hin. Es sei \(G\) eine endliche Gruppe.
openaire   +2 more sources

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

USING THE INTEGRATIVE MODEL TO PREDICT VEGETABLE SUBGROUP CONSUMPTION AMONG COLLEGE STUDENTS [PDF]

open access: yes, 2016
Although eating the recommended amount of vegetables is associated with many health benefits, vegetable consumption is low among college students in the United States.
Senkowski, Valerie
core  

Goal interdependence, Subgroup Formation, and Conflict in Teams

open access: yes, 2017
This research investigates subgroup formation as an important mediator in the goal interdependence-intragroup conflict linkage. Specifically, it proposes that subgroup formation will mediate the relationship between cooperative goal interdependence and ...
Rae, Yunzi Tan
core   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy